Caris Life Sciences® , a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the commercial launch of Caris Detecttm, a groundbreaking ...

Simultaneous tagging of multiple genes with different fluorophores provides a proof of concept for the scalability of tagging all genes in the Caenorhabditis elegans genome.

Sportschosun reporter Jang Jong-ho] A path has opened for the early identification of people at high risk of Alzheimer's ...

Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas ...

Greek oregano is valued worldwide for its strong aroma, culinary appeal, and essential oil (EO) rich in bioactive terpenoids ...

‘The $100 Genome: Where’s the Limit?’ was originally published in April 2024. Few advancements in the life sciences field have been as transformative as the ability to sequence the human genome. Since ...

Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...

AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely a mystery. By Carl Zimmer In 2024, two scientists from Google DeepMind ...

Background: Heart failure (HF) is a leading global cause of morbidity and mortality. Despite therapeutic advances, effective strategies for the primary prevention for HF are limited— particularly in ...

The discovery of CRISPR-Cas9’s gene-editing prowess revolutionized genetic engineering just over a decade ago. Now it appears that genetic engineering technology may be taking its next big leap.

Today, genomics is saving countless lives and even entire species, thanks in large part to a commitment to collaborative and open science that the Human Genome Project helped promote. Twenty-five ...

Balanced chromosomal abnormalities (BCAs) are structural variations that can underlie a wide spectrum of neurodevelopmental disorders, often remaining undetected by conventional diagnostic approaches.